Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Carboplatin did not show benefits in women with ovarian cancer.
Although hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin appeared to be well tolerated in patients with recurrent platinum-sensitive ovarian cancer (a type of chemotherapy), the regimen does not appear to be effective during secondary debulking surgery (at the time of first
The world’s first study using artificial intelligence to establish the risk of ovarian cancer in women
The University of South Australia will lead a world-first study, using artificial intelligence, to establish the risk of the most aggressive reproductive cancer in women worldwide so that it can be detected and treated earlier.